Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture

Journal of Virology

Volumn 80, Issue 18, 2006, Pages 9171-9180

  Barreca, Cristina ^a   O'Hare, Peter ^a  

^a MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERFERON; VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN; CELL SUBPOPULATION; CONDITIONED MEDIUM; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; INNATE IMMUNITY; INTERFERON PRODUCTION; NONHUMAN; PARACRINE SIGNALING; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CHARACTERIZATION; VIRUS CULTURE; VIRUS GENE; VIRUS INFECTION; VIRUS LATENCY; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; CULTURE MEDIA, CONDITIONED; DNA, VIRAL; HERPES SIMPLEX VIRUS PROTEIN VMW65; HERPESVIRUS 1, HUMAN; INTERFERONS; KINETICS; SIGNAL TRANSDUCTION; TIME FACTORS; VERO CELLS;

ANIMALIA; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 33748496675     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00962-06     Document Type: Article

References (45)

1. Altinkilic, B., and G. Brandner. 1988. Interferon inhibits herpes simplex virus-specific translation: a reinvestigation. J. Gen. Virol. 69:3107-3112.
2. Andrejeva, J., D. F. Young, S. Goodbourn, and R. E. Randall. 2002. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76:2159-2167.
3. Baise, E., G. Pire, M. Leroy, J. Gerardin, N. Goris, K. De Clercq, P. Kerkhofs, and D. Desmecht. 2004. Conditional expression of type I interferon-induced bovine Mx1 GTPase in a stable transgenic Vero cell line interferes with replication of vesicular stomatitis virus. J. Interferon Cytokine Res. 24:513-521.
4. Barreca, C., and P. O'Hare. 2004. Suppression of herpes simplex virus 1 in MDBK cells via the interferon pathway. J. Virol. 78:8641-8653.
5. Chee, A. V., and B. Roizman. 2004. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J. Virol. 78:4185-4196.
6. Eidson, K. M., W. E. Hobbs, B. J. Manning, P. Carlson, and N. A. DeLuca. 2002. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76:2180-2191.
7. Flint, S. J., L. W. Enquist, R. M. Krug, V. R. Racaniello, and A. M. Skalka. 2000. Principles of virology. ASM Press, Washington, D.C.
8. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81:2341-2364.
9. Harle, P., B. Sainz, Jr., D. J. Carr, and W. P. Halford. 2002. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology 293:295-304.
10. Harris, R. A., and C. M. Preston. 1991. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in 1814. J. Gen. Virol. 72:907-913.
11. He, B., M. Gross, and B. Roizman. 1997. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiator factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94:843-848.
12. Hill, T. 1985. Herpes simplex virus, latency, p. 175-240. In B. Roizman (ed.), The herpesviruses, vol. 3. Plenum Press, New York, N.Y.
13. Horisberger, M. A., and M. C. Gunst. 1991. Interferon-induced proteins: identification of Mx proteins in various mammalian species. Virology 180:185-190.
14. La Boissière, S., A. Izeta, S. Malcomber, and P. O'Hare. 2004. Compartmentalization of VP16 in cells infected with recombinant herpes simplex virus expressing VP16-green fluorescent protein fusion proteins. J. Virol. 78:8002-8014.
15. Leib, D. A., T. E. Harrison, K. M. Laslo, M. A. Machalek, N. J. Moorman, and H. W. Virgin. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:663-672.
16. Leroy, M., G. Pire, E. Baise, and D. Desmecht. 2006. Expression of the interferon-alpha/beta-inducible bovine Mx1 dynamin interferes with replication of rabies virus. Neurobiol. Dis. 21:515-521. (First published 3 October 2005; doi:10.1016/j.nbd.2005.08.015.)
17. Levy, D. E., and A. Garcia-Sastre. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12:143-156.
18. Lin, R., R. S. Noyce, S. E. Collins, R. D. Everett, and K. L. Mossman. 2004. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J. Virol. 78:1675-1684.
19. Melroe, G. T., N. A. DeLuca, and D. M. Knipe. 2004. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 78:8411-8420.
20. Mittnacht, S., P. Straub, H. Kirchner, and H. Jacobsen. 1988. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 164:201-210.
21. Mossman, K. L., P. F. Macgregor, J. J. Rozmus, A. B. Goryachev, A. M. Edwards, and J. R. Smiley. 2001. Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol. 75:750-758.
22. Mossman, K. L., H. A. Saffran, and J. R. Smiley. 2000. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74:2052-2056.
23. Mossman, K. L., and J. R. Smiley. 2002. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76:1995-1998.
24. Müller-Doblies, D., M. Ackermann, and A. Metzler. 2002. In vitro and in vivo detection of Mx gene products in bovine cells following stimulation with alpha/beta interferon and viruses. Clin. Diagn. Lab. Immunol. 9:1192-1199.
25. Nicholl, M. J., and C. M. Preston. 1996. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific. J. Virol. 70:6336-6339.
26. Nicholl, M. J., L. H. Robinson, and C. M. Preston. 2000. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J. Gen. Virol. 81:2215-2218,
27. Oberman, F., and A. Panel. 1988. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J. Gen. Virol. 69:1167-1177.
28. Openshaw, H., J. I. McNeill, X. H. Lin, J. Niland, and E. M. Cantin. 1995. Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J. Med. Virol. 46:75-80.
29. Preston, C. M., A. N. Harman, and M. J. Nicholl. 2001. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J. Virol. 75:8909-8916.
30. Preston, C. M., and J. Russell. 1991. Retention of nonlinear viral DNA during herpes simplex virus latency in vitro. Intervirology 32:69-75.
31. Russell, J., N. D. Stow, E. C. Stow, and C. M. Preston. 1987. Herpes simplex virus genes involved in latency in vitro. J. Gen. Virol. 68:3009-3018.
32. Sainz, B., Jr., and W. P. Halford. 2002. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76:11541-11550.
33. Samaniego, L. A., L. Neiderhiser, and N. A. DeLuca. 1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72:3307-3320.
34. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
35. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
36. Shiraki, K., and F. Rapp. 1989. Protein analysis of herpes simplex virus latency in vitro established with cycloheximide. Virology 172:346-349.
37. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
38. Stuart-Jamieson, D. R., L. H. Robinson, J. I. Daksis, M. Nicholl, and C. M. Preston. 1995. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. J. Gen. Virol. 76:1417-1431.
39. Su, Y.-H., J. E. Oakes, and R. N. Lausch. 1990. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64:2187-2192.
40. Thiele, K., S. Mittnacht, and H. Kirchner. 1989. Persistent replication of herpes simplex virus type 1 in JOK-1 cells. J. Gen. Virol. 70:1907-1911.
41. Wigdahl, B., A. C. Scheck, R. J. Ziegler, E. De Clerq, and F. Rapp. 1984. Analysis of the herpes simplex virus genome during in vitro latency in human diploid fibroblasts and rat sensory neurons. J. Virol. 49:205-213.
42. Wildy, P., H. J. Field, and A. A. Nash. 1982. Classical herpes latency revisited, p. 133-167. In B. W. J. Mahy, A. C. Minson, and G. K. Darby (ed.), Symposium 33. Society for General Microbiology. Cambridge University Press, Cambridge, United Kingdom.
43. Wu, N., S. C. Watkins, P. A. Schaffer, and N. A. DeLuca. 1996. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70:6358-6369.
44. Yokota, S., N. Yokosawa, T. Kubota, T. Suzutani, I. Yoshida, S. Miura, K. Jimbow, and N. Fujii. 2001. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology 286:119-124.
45. Yokota, S.-I., N. Yokosawa, T. Okabayashi, T. Suzutani, S. Miura, K. Jimbow, and N. Fujii. 2004. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 78:6282-6286.